assembly Bill A336A

Signed By Governor
2021-2022 Legislative Session

Relates to prescribing an opioid antagonist with a patient's first opioid prescription each year

download bill text pdf

Sponsored By

Current Bill Status - Signed by Governor


  • Introduced
  • In Committee
  • On Floor Calendar
    • Passed Senate
    • Passed Assembly
  • Delivered to Governor
  • Signed by Governor

Your Voice

do you support this bill?

Please enter your contact information

Home address is used to determine the senate district in which you reside. Your support or opposition to this bill is then shared immediately with the senator who represents you.

Optional services from the NY State Senate:

Create an account. An account allows you to officially support or oppose key legislation, sign petitions with a single click, and follow issues, committees, and bills that matter to you. When you create an account, you agree to this platform's terms of participation.

Include a custom message for your Senator? (Optional)

Enter a message to your senator. Many New Yorkers use this to share the reasoning behind their support or opposition to the bill. Others might share a personal anecdote about how the bill would affect them or people they care about.

Actions

view actions (17)
Assembly Actions - Lowercase
Senate Actions - UPPERCASE
Dec 30, 2021 signed chap.803
Dec 17, 2021 delivered to governor
Jun 03, 2021 returned to assembly
passed senate
3rd reading cal.904
substituted for s2966a
May 24, 2021 referred to finance
delivered to senate
passed assembly
ordered to third reading rules cal.68
rules report cal.68
reported
May 19, 2021 reported referred to rules
Apr 19, 2021 print number 336a
Apr 19, 2021 amend and recommit to ways and means
Feb 09, 2021 reported referred to ways and means
Jan 06, 2021 referred to health

Co-Sponsors

view additional co-sponsors

Multi-Sponsors

A336 - Details

See Senate Version of this Bill:
S2966
Law Section:
Public Health Law
Laws Affected:
Amd §3309, Pub Health L
Versions Introduced in 2019-2020 Legislative Session:
A5603, S5150

A336 - Summary

Provides that with the first opioid prescription of each year for use in a setting other than a general hospital or nursing home under article twenty-eight of this chapter or facility under article thirty-one of the mental hygiene law, or when a practitioner is prescribing a controlled substance to a patient under the care of hospice, the prescriber shall prescribe an opioid antagonist when any of the following risk factors are present: a history of substance abuse disorder; high dose or cumulative prescriptions that result in 90 morphine milligram equivalents or higher per day; concurrent use of opioids and benzodiazepine or nonbenzodiazepine sedative hypnotics.

A336 - Bill Text download pdf

 
                     S T A T E   O F   N E W   Y O R K
 ________________________________________________________________________
 
                                    336
 
                        2021-2022 Regular Sessions
 
                           I N  A S S E M B L Y
 
                                (PREFILED)
 
                              January 6, 2021
                                ___________
 
 Introduced  by  M.  of A. BRAUNSTEIN, DINOWITZ, OTIS, CYMBROWITZ, AUBRY,
   L. ROSENTHAL, FERNANDEZ, STERN, HEVESI, HUNTER, JOYNER,  PERRY,  RAMOS
   --  Multi-Sponsored by -- M. of A. McDONOUGH -- read once and referred
   to the Committee on Health

 AN ACT to amend the public health law, in  relation  to  prescribing  an
   opioid  antagonist  with  a  patient's  first opioid prescription in a
   given year
 
   THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND  ASSEM-
 BLY, DO ENACT AS FOLLOWS:
 
   Section  1. Section 3309 of the public health law is amended by adding
 a new subdivision 7 to read as follows:
   7. WITH THE FIRST PRESCRIPTION TO A PARTICULAR PATIENT OF AN OPIOID OF
 EACH YEAR FOR USE IN A SETTING OTHER THAN A GENERAL HOSPITAL OR  NURSING
 HOME  UNDER ARTICLE TWENTY-EIGHT OF THIS CHAPTER OR FACILITY UNDER ARTI-
 CLE THIRTY-ONE OF THE MENTAL HYGIENE LAW,  OR  WHEN  A  PRACTITIONER  IS
 PRESCRIBING  A  CONTROLLED  SUBSTANCE  TO  A  PATIENT  UNDER THE CARE OF
 HOSPICE AS DEFINED BY SECTION FOUR THOUSAND TWO  OF  THIS  CHAPTER,  THE
 PRESCRIBER  SHALL PRESCRIBE AN OPIOID ANTAGONIST WHEN ANY OF THE FOLLOW-
 ING RISK FACTORS ARE PRESENT: (A) A HISTORY OF SUBSTANCE  USE  DISORDER;
 (B)  HIGH  DOSE  OR  CUMULATIVE  PRESCRIPTIONS THAT RESULT IN OVER FIFTY
 MORPHINE MILLIGRAM EQUIVALENTS PER DAY; (C) CONCURRENT  USE  OF  OPIOIDS
 AND BENZODIAZEPINE OR NONBENZODIAZEPINE SEDATIVE HYPNOTICS.
   § 2. This act shall take effect on the one hundred eightieth day after
 it  shall have become a law. Effective immediately, the addition, amend-
 ment and/or repeal of any rule or regulation necessary for the implemen-
 tation of this act on its effective date are authorized to be  made  and
 completed  by  the  commissioner  of  health on or before such effective
 date.

  EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets
                       [ ] is old law to be omitted.
                                                            LBD03417-01-1

Co-Sponsors

view additional co-sponsors

Multi-Sponsors

A336A (ACTIVE) - Details

See Senate Version of this Bill:
S2966
Law Section:
Public Health Law
Laws Affected:
Amd §3309, Pub Health L
Versions Introduced in 2019-2020 Legislative Session:
A5603, S5150

A336A (ACTIVE) - Summary

Provides that with the first opioid prescription of each year for use in a setting other than a general hospital or nursing home under article twenty-eight of this chapter or facility under article thirty-one of the mental hygiene law, or when a practitioner is prescribing a controlled substance to a patient under the care of hospice, the prescriber shall prescribe an opioid antagonist when any of the following risk factors are present: a history of substance abuse disorder; high dose or cumulative prescriptions that result in 90 morphine milligram equivalents or higher per day; concurrent use of opioids and benzodiazepine or nonbenzodiazepine sedative hypnotics.

A336A (ACTIVE) - Bill Text download pdf

 
                     S T A T E   O F   N E W   Y O R K
 ________________________________________________________________________
 
                                  336--A
 
                        2021-2022 Regular Sessions
 
                           I N  A S S E M B L Y
 
                                (PREFILED)
 
                              January 6, 2021
                                ___________
 
 Introduced  by  M.  of A. BRAUNSTEIN, DINOWITZ, OTIS, CYMBROWITZ, AUBRY,
   L. ROSENTHAL, FERNANDEZ, STERN, HEVESI, HUNTER, JOYNER, PERRY,  RAMOS,
   STECK, BARRON, McDONALD -- Multi-Sponsored by -- M. of A. McDONOUGH --
   read  once  and  referred  to  the Committee on Health -- reported and
   referred to the Committee on Ways and Means --  committee  discharged,
   bill  amended,  ordered  reprinted  as amended and recommitted to said
   committee
 
 AN ACT to amend the public health law, in  relation  to  prescribing  an
   opioid  antagonist  with  a  patient's  first opioid prescription in a
   given year
 
   THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND  ASSEM-
 BLY, DO ENACT AS FOLLOWS:
 
   Section  1. Section 3309 of the public health law is amended by adding
 a new subdivision 7 to read as follows:
   7. WITH THE FIRST PRESCRIPTION TO A PARTICULAR PATIENT OF AN OPIOID OF
 EACH YEAR FOR USE IN A SETTING OTHER THAN A GENERAL HOSPITAL OR  NURSING
 HOME  UNDER ARTICLE TWENTY-EIGHT OF THIS CHAPTER OR FACILITY UNDER ARTI-
 CLE THIRTY-ONE OF THE MENTAL HYGIENE LAW,  OR  WHEN  A  PRACTITIONER  IS
 PRESCRIBING  A  CONTROLLED  SUBSTANCE  TO  A  PATIENT  UNDER THE CARE OF
 HOSPICE AS DEFINED BY SECTION FOUR THOUSAND TWO  OF  THIS  CHAPTER,  THE
 PRESCRIBER  SHALL PRESCRIBE AN OPIOID ANTAGONIST WHEN ANY OF THE FOLLOW-
 ING RISK FACTORS ARE PRESENT: (A) A HISTORY OF SUBSTANCE  USE  DISORDER;
 (B) HIGH DOSE OR CUMULATIVE PRESCRIPTIONS THAT RESULT IN NINETY MORPHINE
 MILLIGRAM  EQUIVALENTS  OR HIGHER PER DAY; (C) CONCURRENT USE OF OPIOIDS
 AND BENZODIAZEPINE OR NONBENZODIAZEPINE SEDATIVE HYPNOTICS.
   § 2. This act shall take effect on the one hundred eightieth day after
 it shall have become a law. Effective immediately, the addition,  amend-
 ment and/or repeal of any rule or regulation necessary for the implemen-
 tation  of  this act on its effective date are authorized to be made and
 completed by the commissioner of health  on  or  before  such  effective
 date.